Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron L Noland

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|August 23, 2023
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variantsScott A Hollingsworth, Cameron L Noland, Karin Vroom, et al.
Journal of Medicinal Chemistry|February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple MyelomaXiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.
Journal of Medicinal Chemistry|September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Acta Crystallographica. Section D, Structural Biology|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyondJill E Chrencik, Hua Poo Su, Yacob Gomez Llorente, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Scientific Reports|August 23, 2023
Discovery and multimerization of cross-reactive single-domain antibodies against SARS-like viruses to enhance potency and address emerging SARS-CoV-2 variantsScott A Hollingsworth, Cameron L Noland, Karin Vroom, et al.
Journal of Medicinal Chemistry|February 5, 2019
Optimization of Pan-Pim Kinase Activity and Oral Bioavailability Leading to Diaminopyrazole (GDC-0339) for the Treatment of Multiple MyelomaXiaojing Wang, Wesley Blackaby, Vivienne Allen, et al.
Nature Cancer|June 5, 2023
An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistanceThijs J Hagenbeek, Jason R Zbieg, Marc Hafner, et al.
Journal of Medicinal Chemistry|September 30, 2016
Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300Terry D Crawford, F Anthony Romero, Kwong Wah Lai, et al.
Acta Crystallographica. Section D, Structural Biology|May 26, 2026
The evolving role of structural biology in pharma: integration of X-ray crystallography, cryo-electron microscopy and beyondJill E Chrencik, Hua Poo Su, Yacob Gomez Llorente, et al.
Pageof 3